🇺🇸 cidofovir 1% topical ointment in United States

FDA authorised cidofovir 1% topical ointment on 27 June 2012

Marketing authorisations

FDA — authorised 27 June 2012

  • Application: ANDA201276
  • Marketing authorisation holder: MYLAN INSTITUTIONAL
  • Local brand name: CIDOFOVIR
  • Indication: SOLUTION — INTRAVENOUS
  • Status: approved

Read official source →

FDA — authorised 26 July 2012

  • Application: ANDA202501
  • Marketing authorisation holder: AVET LIFESCIENCES
  • Local brand name: CIDOFOVIR
  • Indication: SOLUTION — INTRAVENOUS
  • Status: approved

Read official source →

Other Infectious Diseases approved in United States

Frequently asked questions

Is cidofovir 1% topical ointment approved in United States?

Yes. FDA authorised it on 27 June 2012; FDA authorised it on 26 July 2012.

Who is the marketing authorisation holder for cidofovir 1% topical ointment in United States?

MYLAN INSTITUTIONAL holds the US marketing authorisation.